Periodontal manifestations of collagen vascular disorders

Periodontology 2000

Volumn 21, Issue 1, 1999, Pages 94-105

  Gonzales, Theresa S ^a   Coleman, Gary C ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AUTOIMMUNE DISEASE; CONNECTIVE TISSUE DISEASE; HUMAN; PERIODONTAL DISEASE; REVIEW;

AUTOIMMUNE DISEASES; CONNECTIVE TISSUE DISEASES; HUMANS; PERIODONTAL DISEASES;

EID: 0033212168     PISSN: 09066713     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0757.1999.tb00170.x     Document Type: Article

References (74)

1. Adelman DC, Saltiel E, Klinenberg JR. The neuropsychiatric manifestations of systemic lupus erythematosus: an overview. Semin Arthritis Rheum 1986: 15: 185-199.
2. Alarcón-Segovia D, Ibánez G, Hernández-Ortiz J, Velázquez-Forero F, González-Jiménez Y. Sjögren's syndrome in progressive systemic sclerosis (scleroderma). Am J Med 1974: 57: 78-85.
3. Alarcon-Segovia D. Mixed connective tissue disease: a decade of growing pains. J Rheumatol 1981: 8: 535-540.
4. Alexandridis C, White SC. Periodontal ligament changes in patients with progressive systemic sclerosis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1984: 58: 113-118.
5. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arch Rheum 1988: 31: 315-324.
6. Atkinson JC, Fox PC. Sjögren's syndrome: oral and dental considerations. J Am Dent Assoc 1993: 124: 74-86.
7. Bromley M, Woolley DE. Histopathology of the rheumatoid lesion. Identification of cell types at sites of cartilage erosin. Arthritis Rheum 1984: 27: 857-863.
8. Burge SM, Frith PA, Juniper RP, Wojnarowska F. Mucosal involvement in systemic and chronic cutaneous lupus erythematosus. Br J Dermatol 1989: 121: 727-741.
9. Cervera R, Khamashta MA, Font JH, Sebastiani GD, Gil A, Lavilla P, Domenech I, Aydintug AO, Jedryka-Goral A, De Ramon E, Galeazzi M, Haga J, Mathieu A, Houssiau F, Ingelmo M, Hughes GRV. Systemic lupus erythematosus: clinical immunologic patterns of disease in a cohort of 1,000 patients. Medicine 1993: 72: 113-124.
10. Claman HN, Giorno R, Seibold JR. Endothelial and fibroblastic activation in scleroderma: the myth of the "uninvolved skin". Arthritis Rheum 1991: 34: 1495-1501.
11. Cotran RS, Kumar V, Robbins SL. Robbins pathologic basis of disease. 4th edn. Philadelphia: WB Saunders, 1989.
12. Daniels TE. Labial salivary gland biopsy in Sjögren's syndrome. Assessment as a diagnostic criterion in 362 suspected cases. Arthritis Rheum 1984: 27: 147-156.
13. Diamond B, Katz JB, Paul E, Aranow C, Lustgarten D, Scharff MD. The role of somatic mutation in the pathogenic anti-DNA response. Annu Rev Immunol 1992: 10: 731-757.
14. Doherty PC, Allan W, Eichelberger M, Carding SR. Heatshock proteins and the Tyg-cell response in virus infections: implications for autoimmunity. Springer Semin Immunopathol 1991: 13: 11-24.
15. Douvas A. Does Scl-70 modulate collagen production in systemic sclerosis? Lancet 1988: 2: 475-477.
16. Drosos AA, Andonopoulos AP, Costopoulos JS, Stavropoulos ED, Papadimitriou CS, Moutsopoulos JM. Sjögren's syndrome in progressive systemic sclerosis. J Rheumatol 1988: 15: 965-968.
17. Drosos AA, Pennec YL, Elisaf M, Lamour A, Acritidis NC, Jouquan JR, Moutsopoulos HM, Youinou P. Sjögren's syndrome in patients with the CREST variant of progressive systemic scleroderma. J Rheumatol 1991: 18: 1685-1688.
18. Dubois EL, Arteberry JD. Etiology of discord and systemic lupus erythematosus. In: Dubois EL, ed. Lupus erythematosus. 2nd edn. Los Angeles: University of Southern California Press, 1976: 90-123.
19. Eastgate JA, Symons JA, Wood NC, Grinlinton FM, di Giovine FS, Duff GW. Correlation of plasma interleukin 1 levels with disease activity in rheumatoid arthritis. Lancet 1988: 2: 706-709.
20. Ehrlich P, Morgenroth J. On haemolysins. Fifth Communication. Berl Klin Wochenschr [reprinted in English translation in The Collected Papers of Paul Ehrlich] New York: Pergamon, 1957: 246-255.
21. Eversole LR, Jacobsen PL, Stone CE. Oral and gingival changes in systemic sclerosis (scleroderma). J Periodontol 1984: 55: 175-178.
22. Fernandes G, Talal N. SLE: hormones and diet. Clin Exp Rheumatology 1986: 4: 183-185.
23. Fessel WJ. Systemic lupus erythematosus in the community. Incidence, prevalence, outcome and first symptoms; the high prevalence in black women. Arch Intern Med 1974: 134: 1027-1035.
24. Fox RI, Robinson CA, Curd JG, Kozin F, Howell FV. Sjögren's syndrome. Proposed criteria for classification. Arthritis Rheum 1986: 29: 577-585.
25. Fox RI, Kang H-I. Pathogenesis of Sjögren's syndrome. Rheum Dis Clin North Am 1992: 18: 571-589.
26. Gores RJ. Dental characteristics associated with acrosclerosis and diffuse scleroderma. J Am Dent Assoc 1957: 54: 755-759.
27. Green D. Scleroderma and its oral manifestations. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1962: 15: 1312-1324.
28. Gregersen PK, Silver J, Windrester RJ. The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum 1987: 30: 1205-1213.
29. Helfrich DJ, Banner B, Steen VD, Medsger TA Jr. Normotensive renal failure in systemic sclerosis. Arthritis Rheum 1989: 32: 1128-1134.
30. Heraman A, Kappler JW, Marrack P, Pullen AM. Superantigens - mechanism of T-cell stimulation and role in immune responses. Annu Rev Immunol 1991: 9: 745-772.
31. Hochberg MC. The epidemiology of systemic lupus erythematosus. In: Wallnee DJ, Han BH, ed. Dubois' lupus erythematosus. 4th edn. Philadelphia: Lea and Febiger, 1993: 49-52.
32. Hopper FE, Giles AD. Orofaclal changes in systemic sclerosis - report of a case of resorption of mandibular angles and zygomatic arches. Br J Oral Surg 1982: 20: 129-134.
33. Horgan C, Johnson RJ, Gauthier J, Mannik M, Emlen W. Binding of double-stranded DNA to glomeruli of rats in vivo. Arthritis Rheum 1989: 32: 298-305.
34. Inoshita T, Whiteside TL, Rodnan GP, Taylor FH. Abnormalities of T lymphocyte subsets in patients with progressive systemic sclerosis (PSS, scleroderma). J Lab Clin Med 1981: 97: 264-277.
35. Jonsson R, Bratthall D, Nyberg G. Histologic and sialochemical findings indicating sicca syndrome in patients with systemic lupus erythematosus. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1982: 54: 635-639.
36. Jonsson R, Heyden G, Westberg NG, Nyberg G. Oral mucosal lesions in systemic lupus erythematosus - a clinical, histopathological and immunopathological study. J Rheumatol 1984: 11: 38-42.
37. Kassan SS, Thomas TL, Moutsopoulos HM, Hoover R, Kimberly RP, Budman DR, Costa J, Decker JL, Chused TM. Increased risk of lymphoma in sicca syndrome. Ann Intern Med 1978: 89: 888-892.
38. Kronenberg M. Self tolerance and autoimmunity. Cell 1991: 65: 537.
39. Larheim TA, Bjornland T. Arthrographic findings in the temporomandibular joint in patients with rheumatic disease. J Oral Maxillofac Surg 1989: 47: 780-784.
40. LeRoy EC. Connective tissue synthesis by scleroderma skin fibroblasts in cell culture. J Exp Med 1972: 135: 1351-1362.
41. LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA Jr, Rowell N, Wollheim F. Scleroderma (systemic sclerosis): classification, subsets, and pathogenesis. J Rheumatol 1988: 15: 202-205.
42. Manthorpe R, Oxholm P, Prause JN, Schiodt M. Sjögren's syndrome: comments on the proposed criteria for classification. Arthritis Rheum 1987: 30: 954-956.
43. Marmary Y, Glaiss R, Pisanty S. Scleroderma: oral manifestations. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1981: 52: 32-37.
44. Masi AT. Classification of systemic sclerosis (scleroderma): relationship of cutaneous subgroups in early disease to outcome and serologic reactivity. J Rheumatol 1988: 15: 894-898.
45. Morahan G, Brennan FE, Bhathal PS, Allison J. Expression in transgenic mice of class I histocompatibility antigens controlled by the metallothionin promoter. Proc Natl Acad Sci U S A 1989: 86: 3782-3786.
46. Nagy G, Kovacs J, Zeher M, Czirjak L. Analysis of the oral manifestations of systemic sclerosis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1994: 77: 141-146.
47. Najera MP, Al-Hashimi I, Plemons JM, Rivera-Hidalgo F, Rees TD, Haghighat N, Wright JM. Prevalence of periodontal disease in patients with Sjögreris syndrome. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1997: 83: 453-457.
48. Nakamura MC, Nakamura RM. Contemporary concepts of autoimmunity and autoimmune diseases. J Clin Lab Anal 1992: 6: 275-289.
49. Nisengard RJ. Periodontal implication: mucocutaneous disorders. Ann Periodontol 1996: 401-438.
50. Nossent JC, Huysen V Smeenk RJT, Swaak AJG. Low avidity antibodies to DS DNA as a diagnostic tool. Ann Rheum Dis 1989: 48: 748-752.
51. Osial TA, Whiteside TL, Buckingham RB, Singh G, Barnes EL, Pierce JM, Rodnan GP. Clinical and serologic study of Sjögren's syndrome in patients with progressive systemic sclerosis. Arthritis Rheum 1983: 26: 500-508.
52. Paley M, McLoughlin P. Oral problems associated with CREST syndrome: a case report. Br Dent J 1993: 175: 295-296.
53. Paul WE. Fundamental immunology. 3rd edn. New York: Raven Press, 1993: 1033-1097.
54. Rhodus NL, Johnson DK. The prevalence of oral manifestations systemic lupus erythematosus. Quintessence Int 1990: 21: 461-465.
55. Rosenbaum JT. Acute anterior uveitis and spondyloarthropathies. Rheum Dis Clin North Am 1992: 18: 143-151.
56. Schiodt M. Oral manifestations of lupus erythematosus. Int J Oral Surg 1984: 13: 101-147.
57. Schumacher HR, Gall EP. Rheumatoid arthritis: an illustrated guide to pathology, diagnosis, and management. Philadelphia: JB Lippincott, 1988.
58. Seifert MH, Sterigerwald JC, Cliff MM. Bone resorption of the mandible in progressive systemic sclerosis. Arthritis Rheum 1975: 18: 507-512.
59. Sell S. Immunology, immunopathology, and immunity. 5th edn. Stamford, CT: Appleton and Lange, 1996: 527-587.
60. Sharp GC, Irvin WS, Tan EM, Gould RG, Holman HR. Mixed connective tissue disease - an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA). Am J Med 1972: 52: 148-159.
61. Stafne EC, Austin LT. A characteristic dental finding in acrosclerosis and diffuse scleroderma. Am J Orthodontic Oral Surg 1944: 30: 25-29.
62. Staples PJ, Gerding DN, Decker JL, Gordon Rs. Incidence of infection in systemic lupus erythematosus. Arthritis Rheum 1974: 17: 1-10.
63. Tseng CC, Wolff LF, Rhodus N, Aeppli DM. The periodontal status of patients with Sjögren's syndrome. J Clin Periodontol 1990: 17: 329-330.
64. Tseng CC. Periodontal status of patients with Sjögren's syndrome: a cross sectional study. J Formosan Med Assoc 1991: 90: 109-111.
65. Tuffanelli DL, Winkleman RK. Systemic scleroderma: a clinical study of 727 cases. Arch Dermatol 1961: 84: 359.
66. Velayos EE, Masi AT, Stevens MB, Shulman LE. The CREST syndrome, comparison with systemic sclerosis (scleroderma). Arch Intern Med 1979: 139: 1240-1244.
67. Wallace DJ Hahn GH, Klippel JH. Lupus Nephritis. In: Wallace DJ, Hahn GH, ed. Dubois' lupus erythematosus. 4th edn. Philadelphia: Lea and Febiger, 1993: 542-549.
68. Weisman RA, Calcaterra TC. Head and neck manifestations of scleroderma. Ann Otol 1978: 87: 332-339.
69. White SC, Frey NW, Blaschke DD, Ross MD, Clements PJ, Furst DE, Paulus HE. Oral radiographic changes in patients with progressive systemic sclerosis (scleroderma). J Am Dent Assoc 1977: 94: 1178-1182.
70. Wilske KR, Healy LA. Challenging the therapeutic pyramid: A new look at treatment strategies for rheumatoid arthritis. J Rheum 1990: 17(suppl 25): 4.
71. Wood RE, Lee P. Analysis of the oral manifestations of systemic sclerosis (scleroderma). Oral Surg Oral Med Oral Pathol Oral Radlol Endod 1988: 65: 172-178.
72. Yancey KB, Lawley TJ. Disorders of the immune system, connective tissue and joints in Harrison's principles of internal medicine. 14th edn. New York: McGraw-Hill, 1998: 1876.
73. Zide MF, Carlton DM, Kent JN. Rheumatoid disease and related arthropathies: I. Systemic findings, medical therapy, and peripheral joint surgery. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1986: 61: 119-125.
74. Zulman J, Jaffe R, Talal N. Evidence that the malignant lymphoma of Sjögren's syndrome is a monoclonal B-cell neoplasm. N Engl J Med 1978: 299: 1215-1220.